Detecting waning serological response with commercial immunoassays: 18-month longitudinal follow-up of anti-SARS-CoV-2 nucleocapsid antibodies
Y Nakagama, Y Komase, N Kaku, Y Nitahara… - Microbiology …, 2022 - Am Soc Microbiol
Past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an important
determinant of protection from reinfection and of postvaccine immune responses. Herein, …
determinant of protection from reinfection and of postvaccine immune responses. Herein, …
Antibody avidity maturation following recovery from infection or the booster vaccination grants breadth of SARS-CoV-2 neutralizing capacity
…, S Nakagama, C Watanabe, Y Nitahara… - The Journal of …, 2023 - academic.oup.com
Background Cross-neutralizing capacity of antibodies against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) variants is important in mitigating (re-)exposures. Role of …
syndrome coronavirus 2 (SARS-CoV-2) variants is important in mitigating (re-)exposures. Role of …
A dual-antigen SARS-CoV-2 serological assay reflects antibody avidity
Y Nakagama, Y Nitahara, N Kaku… - Journal of Clinical …, 2022 - Am Soc Microbiol
Serial antibody measurements using an array of SARS-CoV-2 immunoassays have
demonstrated differing kinetics among assay platforms (1). Immunoassays utilizing a double-antigen …
demonstrated differing kinetics among assay platforms (1). Immunoassays utilizing a double-antigen …
High-resolution linear epitope mapping of the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 mRNA vaccine recipients
Y Nitahara, Y Nakagama, N Kaku… - Microbiology …, 2021 - Am Soc Microbiol
The prompt rollout of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
mRNA vaccine is facilitating population immunity, which is becoming more dominant than …
mRNA vaccine is facilitating population immunity, which is becoming more dominant than …
[HTML][HTML] Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort …
…, K Matsumoto, A Suita, E Komiya, E Mukai, Y Nitahara… - Vaccine, 2022 - Elsevier
Background Although several assays are used to measure anti-receptor-binding domain (RBD)
antibodies induced after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2…
antibodies induced after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2…
Serological testing reveals the hidden COVID-19 burden among health care workers experiencing a SARS-CoV-2 nosocomial outbreak
…, H Kunishima, T Imai, A Shintani, Y Nitahara… - Microbiology …, 2021 - Am Soc Microbiol
We describe the results of testing health care workers, from a tertiary care hospital in Japan
that had experienced a coronavirus disease 2019 (COVID-19) outbreak during the first peak …
that had experienced a coronavirus disease 2019 (COVID-19) outbreak during the first peak …
[HTML][HTML] Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine …
…, N Kaku, K Matsumoto, A Suita, E Mukai, Y Nitahara… - Scientific Reports, 2024 - nature.com
To evaluate the antibody response following the initial four doses of mRNA vaccines (BNT162b2
or mRNA-1273) in SARS-CoV-2-naïve healthy adults and investigate factors …
or mRNA-1273) in SARS-CoV-2-naïve healthy adults and investigate factors …
[HTML][HTML] Re-emerging threat of Trypanosoma cruzi vector transmission in El Salvador, update from 2018 to 2020
MS Rodríguez, Y Nitahara, M Cornejo… - Infectious Diseases of …, 2022 - Springer
Background Since the late twentieth century, Chagas disease gained global attention to
suppress the vector burden as a main control strategy in endemic countries. In Central America, …
suppress the vector burden as a main control strategy in endemic countries. In Central America, …
[HTML][HTML] Mesenchymal stem cells overexpressing interleukin-10 promote neuroprotection in experimental acute ischemic stroke
…, A Nakamura-Takahashi, Y Nitahara-Kasahara… - … Therapy-Methods & …, 2017 - cell.com
Interleukin (IL)-10 is a contributing factor to neuroprotection of mesenchymal stem cell (MSC)
transplantation after ischemic stroke. Our aim was to increase therapeutic effects by …
transplantation after ischemic stroke. Our aim was to increase therapeutic effects by …
Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes
…, H Hayashita-Kinoh, Y Nitahara-Kasahara… - Human gene …, 2009 - liebertpub.com
In vivo gene transduction with adeno-associated virus (AAV)-based vectors depends on
laborious procedures for the production of high-titer vector stocks. Purification steps for efficient …
laborious procedures for the production of high-titer vector stocks. Purification steps for efficient …